Purging of Autologous Peripheral-Blood Stem Cells Using CD34 Selection Does Not Improve Overall or Progression-Free Survival After High-Dose Chemotherapy for Multiple Myeloma: Results of a Multicenter Randomized Controlled Trial
STEWART, A. Keith, VESCIO, Robert, STIFF, Pat, MEHARCHARD, Jacinta, SCHLOSSMAN, Robert, BROWN, Randy, TULLY, Heather, BENYUNES, Mark, JACOBS, Cindy, BERENSON, Ronald, WHITE, Michael, DIPERSIO, John, SCHILLER, Gary, ANDERSON, Kenneth C, BERENSON, James, BALLESTER, Oscar, NOGA, Stephen, RUGO, Hope, FREYTES, Cesar, STADTMAUER, Edward, TARANTOLO, Stefano, SAHEBI, Firoozeh
Published in Journal of clinical oncology (01.09.2001)
Published in Journal of clinical oncology (01.09.2001)
Get full text
Journal Article
Multicenter Phase III Trial to Evaluate CD34+ Selected Versus Unselected Autologous Peripheral Blood Progenitor Cell Transplantation in Multiple Myeloma
Vescio, Robert, Schiller, Gary, Stewart, A. Keith, Ballester, Oscar, Noga, Stephen, Rugo, Hope, Freytes, Cesar, Stadtmauer, Edward, Tarantolo, Stefano, Sahebi, Firoozeh, Stiff, Pat, Meharchard, Jacinta, Schlossman, Robert, Brown, Randy, Tully, Heather, Benyunes, Mark, Jacobs, Cindy, Berenson, Ronald, DiPersio, John, Anderson, Ken, Berenson, James
Published in Blood (15.03.1999)
Published in Blood (15.03.1999)
Get full text
Journal Article